U.S. Marine and Shipping Stock News

OTCPK:ABXX.F
OTCPK:ABXX.FSoftware

A Look at Abaxx Technologies (OTCPK:ABXX.F) Valuation After ARTEX Partnership and Enwex German Wind Futures Launch

Abaxx Technologies (OTCPK:ABXX.F) has been in the spotlight following two key moves: a partnership with ARTEX AG to modernize asset trading and the launch of the Enwex German Wind Futures contract. These developments highlight Abaxx's expanding global reach and focus on market infrastructure innovation. See our latest analysis for Abaxx Technologies. After a year of eye-catching developments, Abaxx Technologies is drawing more attention from growth-minded investors. The 237.5% year-to-date...
NasdaqCM:FTCI
NasdaqCM:FTCIElectrical

A Look at FTC Solar’s Valuation Following Strong Q3 Results, Strategic Deals, and Guidance for Growth

FTC Solar, a US-based solar technology firm, delivered third quarter 2025 earnings that outperformed market forecasts and sent the stock higher. The company’s revenue jumped sharply year over year, and it returned to gross profit positivity. See our latest analysis for FTC Solar. FTC Solar’s upbeat third-quarter results have helped fuel a major reversal in sentiment. The stock is now at $10.43 after surging more than 80% year-to-date. While one-day swings remain sharp, the recent run is...
NasdaqCM:SMTI
NasdaqCM:SMTIMedical Equipment

Sanara MedTech (SMTI): Fresh Focus on Surgical Business Prompts New Look at Valuation After Earnings Beat and Business Shift

Sanara MedTech (SMTI) has caught investor attention after announcing plans to discontinue its Tissue Health Plus segment in addition to reporting strong third quarter earnings results. The company is refocusing resources on its core surgical business. See our latest analysis for Sanara MedTech. Sanara MedTech’s announcement to exit the Tissue Health Plus business and focus on its surgical division arrived after a volatile stretch for shareholders. Despite last week’s sharp one-day share price...
NasdaqCM:COOP
NasdaqCM:COOPDiversified Financial

Reassessing Mr. Cooper Group (COOP) Valuation After Major Shareholder David Nierenberg Cuts Stake by 57%

Mr. Cooper Group (COOP) drew attention after investor David Nierenberg cut his position in the company by 57%, selling over 169,000 shares. Moves like this from prominent shareholders often cause investors to wonder what could come next for the stock. See our latest analysis for Mr. Cooper Group. It’s been quite a ride for Mr. Cooper Group this year. After a remarkable stretch, including a 15.6% 1-month share price return and an eye-popping 132.4% total shareholder return over the past 12...
NasdaqCM:CURI
NasdaqCM:CURIEntertainment

A Look at CuriosityStream (CURI) Valuation Following AI Licensing Growth and New Dividend Initiatives

CuriosityStream (CURI) caught investor attention this week after reporting sizeable revenue growth and revealing a strategic push into AI video training data licensing. The company’s new focus aims to unlock higher-margin and steadier revenue streams. See our latest analysis for CuriosityStream. Momentum has clearly picked up for CuriosityStream this year, with a 16% jump in share price over the past week and a staggering 189% year-to-date share price return. This sharp rebound follows upbeat...
NasdaqGM:CVAC
NasdaqGM:CVACBiotechs

Does CureVac’s 108% Rally Signal a Smarter Opportunity After mRNA Breakthrough News?

Ever wondered whether CureVac's stock is a hidden gem or a value trap? You're not alone as many investors are taking a closer look after a wild ride. Despite a turbulent three-year stretch, CureVac shares are up an eye-popping 107.9% in the past year, with a year-to-date gain of 53% sparking new optimism and debate about its outlook. Recent attention around CureVac has centered on developments in its mRNA vaccine research as well as fresh updates on ongoing clinical trials. These...